chartexchange

TSHA
Taysha Gene Therapies, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
4.00USD0.000%(0.00)3,551,736
Pre-marketNov 18, 2026 9:29:30 AM EST
3.96USD-1.000%(-0.04)
After-hoursNov 18, 2026 4:00:30 PM EST
3.99USD-0.250%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Dallas, TX, USA
Previous Close
$4.00
Beta
1.73
52-Week High
$7.30 2026-05-06
52-Week Low
$3.46 2026-10-14
SMA 50
$4.40
SMA 200
$5.29
Avg. Vol 10D
3.28M
Avg. Vol 30D
3.65M
Avg. Vol 90D
3.36M
Relative Vol
0.97
325.83M
274.55M
53,478,497
0.4100%
2,000,000
337
TSHA Profile

taysha gene therapies, inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. it primarily develops tsha-101 for the treatment of gm2 gangliosidosis; tsha-118 for the treatment of cln1 disease; tsha-102 for the treatment of rett syndrome; tsha-103 for the treatment of slc6a1 haploinsufficiency disorder; and tsha-104 for the treatment for surfeit locus 1 deficiency. the company also has strategic partnership with the university of texas southwestern medical center to develop and commercialize transformative gene therapy treatments. taysha gene therapies, inc. was founded in 2019 and is based in dallas, texas.

TSHA Performance
PeriodPriceDateChangeBeta
1W4.212026-11-12-5.11%-0.232
1M3.942026-10-19+1.40%1.590
3M6.432026-08-19-37.87%1.301
6M5.192026-05-19-22.95%1.354
1Y4.012025-11-19-0.37%1.728
2Y2.122024-11-19+88.44%—
5Y13.492021-11-19-70.39%1.833
TSHA Stock Summary

Taysha Gene Therapies, Inc. Common Stock (NASDAQ:TSHA) stock price today is $4.00, and today's volume is 3,551,736. TSHA is down 0.125% today. The 30 day average volume is 3.65M. TSHA market cap is $1.30B with 325.83M shares outstanding.